Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...magdy elmasry
Cardiologists and diabetes.Target organs and action mechanism of antidiabetic drugs.Cardiovascular Outcome Trials
( CVOTs ) in Diabetes.Completed and ongoing CVOTs in type 2 diabetes.Diabetes Medications
and
Cardiovascular Impact.Recommendations for management of diabetes
Cardiovascular safety of anti-diabetic drugs.
ARBs (Angiotensin receptor blockers) are the most widely used anti hypertensive throughout the world. A solid knowledge related to ARB will make our practice more patients friendly & benefit will be maximum.
Cardiovascular safety of anti-diabetic drugs.Cardiovascular Outcome Trials ...magdy elmasry
Cardiologists and diabetes.Target organs and action mechanism of antidiabetic drugs.Cardiovascular Outcome Trials
( CVOTs ) in Diabetes.Completed and ongoing CVOTs in type 2 diabetes.Diabetes Medications
and
Cardiovascular Impact.Recommendations for management of diabetes
Cardiovascular safety of anti-diabetic drugs.
ARBs (Angiotensin receptor blockers) are the most widely used anti hypertensive throughout the world. A solid knowledge related to ARB will make our practice more patients friendly & benefit will be maximum.
Calcium channel blockers are useful treatments in the management of hypertension. In this presentation by Dr Vivek Baliga, we look at the added benefits of newer types of CCBs in treating high blood pressure. Read more from Dr Baliga here - http://drvivekbaliga.net
This particular presentation of mine covers salient features of recent drug developed for treatment of dyslipidaemia particularly familial hypercholesterolemia. This presentation also covers recent modifications in treatment guidelines.
Beta Blockers in current cardiovascular practice Praveen Nagula
betablockers are the drug of choice for prevention of progression of heart failure with mortality benefit, after the evolution of neurohormonal regulation as pathogenesis of heart failure
#flozins
🫀DAPA 🆚placebo in HFpEF
Now we have a positive trial!
⬇️18% in CV☠️ death or
worsening HF among LVEF>40%
⬇️ 21%heart failure
💥Results same for LVEF> 60% 🆚LVEF<60%
Calcium channel blockers are useful treatments in the management of hypertension. In this presentation by Dr Vivek Baliga, we look at the added benefits of newer types of CCBs in treating high blood pressure. Read more from Dr Baliga here - http://drvivekbaliga.net
This particular presentation of mine covers salient features of recent drug developed for treatment of dyslipidaemia particularly familial hypercholesterolemia. This presentation also covers recent modifications in treatment guidelines.
Beta Blockers in current cardiovascular practice Praveen Nagula
betablockers are the drug of choice for prevention of progression of heart failure with mortality benefit, after the evolution of neurohormonal regulation as pathogenesis of heart failure
#flozins
🫀DAPA 🆚placebo in HFpEF
Now we have a positive trial!
⬇️18% in CV☠️ death or
worsening HF among LVEF>40%
⬇️ 21%heart failure
💥Results same for LVEF> 60% 🆚LVEF<60%
Anti anginal drugs, uses, mechanism of action, adverse effectsKarun Kumar
A presentation outlining the causes of angina, mechanism of action of various anti-anginal drugs, their uses and side effects alongwith contraindications
Pharmacotherapy of congestive heart faliure Rahulvaish13
This PPT covers the pathophysiology, treatment protocol and details of individual drugs used and those drugs failed in clinical trials; taken from standard text books and articles as reference. This will be extremely useful for undergraduates ( MBBS, BDS,) and postgraduates (MD,MDS ,Phd).
Vitamin D is an important prohormone for optimal intestinal calcium absorption for mineralization of bone. Because the vitamin D receptor is present in multiple tissues, there has been interest in evaluating other potential functions of vitamin D, particularly, in cardiovascular diseases (CVD). Cross-sectional studies have reported that vitamin D deficiency is associated with increased risk of CVD, including hypertension, heart failure, and ischemic heart disease. Initial prospective studies have also demonstrated that vitamin D deficiency increases the risk of developing incident hypertension or sudden cardiac death in individuals with preexisting CVD. Very few prospective clinical studies have been conducted to examine the effect of vitamin D supplementation on cardiovascular outcomes. The mechanism for how vitamin D may improve CVD outcomes remains obscure; however, potential hypotheses include the downregulation of the renin-angiotensin-aldosterone system, direct effects on the heart, and vasculature or improvement of glycemic control. This review will examine the epidemiologic and clinical evidence for vitamin D deficiency as a cardiovascular risk factor and explore potential mechanisms for the cardioprotective effect of vitamin D.
How to deal with CALCIFIED CORONARY ARTERY LESIONS .Coronary artery calcification (CAC) is highly prevalent in patients with coronary heart disease (CHD) and is associated with major adverse cardiovascular events. There are two recognized type of CAC—intimal and medial calcification, and each of them have specific risk factors. Several theories about the mechanism of vascular calcification have been put forward, and we currently believe that vascular calcification is an active, regulated process. CAC can usually be found in patients with severe CHD, and this asymptomatic phenomenon make early diagnosis of CAC important. Coronary computed tomographic angiography is the main noninvasive tool to detect calcified lesions. Measurement of coronary artery calcification by scoring is a reasonable metric for cardiovascular risk assessment in asymptomatic adults at intermediate risk. To date, effective medical treatment of CAC has not been identified. Several strategies of percutaneous coronary intervention have been applied to CHD patients with CAC, but with unsatisfactory results. Prognosis of CAC is still a major problem of CHD patients. Thus, more details about the mechanisms of CAC need to be elucidated in order to improve the understanding and treatment of CAC.
Hypertension is a common medical and social problem leading to cardiovascular diseases worldwide. Antihypertensive drugs are clinically applied to decrease the morbidity and mortality induced by hypertension itself and its complications. The 2014 hypertension guideline of the Eighth Joint National Committee (JNC8) for hypertension therapy in the United States has made several significant changes with respect to the clinical management of hypertension and the initiative medications, as compared with the previous guidelines. In addition to the instructions that pharmacologic treatment should be initiated when blood pressure (BP) is 150/90 mmHg or higher in adults over 60 years, 140/90 mmHg in adults younger than 60 years, or 140/90 mmHg or higher (regardless of age) in patients with hypertension and diabetes, a thiazide-type diuretic, calcium (Ca2+) channel blocker (CCB), angiotensin-converting enzyme inhibitor (ACEI), or angiotensin receptor blocker (ARB) should be considered to start an initial antihypertensive medication in non-black population. In black population with or without diabetes, initial antihypertensive treatment should include a thiazide-type diuretic or CCB. Thus, CCB has become one of the most important initial agents for antihypertensive monotherapy. Furthermore, since CCBs have been proved not to increase the risk of coronary events and stroke,CCBs appear to be a favorable choice for monotherapy as well as for combination with other agent classes in the treatment of hypertension and may provide specific benefits beyond BP lowering.Nowadays, dihydropyridine (DHP) CCBs are one group of most frequently prescribed antihypertensive medications in China and other Eastern Asian countries.
Among patients with or at high risk of CVD, use of an FDC strategy for blood pressure, cholesterol, and platelet control vs usual care resulted in significantly improved medication adherence.Polypill therapy significantly improved adherence, SBP and LDL-cholesterol in high risk patients compared with usual care, especially among those who were under-treated at baseline.
A transesophageal echocardiogram (TEE) uses echocardiography to assess the structure and function of the heart. During the procedure, a transducer (like a microphone) sends out ultrasonic sound waves. When the transducer is placed at certain locations and angles, the ultrasonic sound waves move through the skin and other body tissues to the heart tissues, where the waves bounce or "echo" off of the heart structures. The transducer picks up the reflected waves and sends them to a computer. The computer displays the echoes as images of the heart walls and valves.
A traditional echocardiogram is done by putting the transducer on the surface of the chest. This is called a transthoracic echocardiogram. A transesophageal echocardiogram is done by inserting a probe with a transducer down the esophagus. This provides a clearer image of the heart because the sound waves do not have to pass through skin, muscle, or bone tissue. The TEE probe is much closer to the heart since the esophagus and heart are right next to each other.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
The Roman Empire A Historical Colossus.pdfkaushalkr1407
The Roman Empire, a vast and enduring power, stands as one of history's most remarkable civilizations, leaving an indelible imprint on the world. It emerged from the Roman Republic, transitioning into an imperial powerhouse under the leadership of Augustus Caesar in 27 BCE. This transformation marked the beginning of an era defined by unprecedented territorial expansion, architectural marvels, and profound cultural influence.
The empire's roots lie in the city of Rome, founded, according to legend, by Romulus in 753 BCE. Over centuries, Rome evolved from a small settlement to a formidable republic, characterized by a complex political system with elected officials and checks on power. However, internal strife, class conflicts, and military ambitions paved the way for the end of the Republic. Julius Caesar’s dictatorship and subsequent assassination in 44 BCE created a power vacuum, leading to a civil war. Octavian, later Augustus, emerged victorious, heralding the Roman Empire’s birth.
Under Augustus, the empire experienced the Pax Romana, a 200-year period of relative peace and stability. Augustus reformed the military, established efficient administrative systems, and initiated grand construction projects. The empire's borders expanded, encompassing territories from Britain to Egypt and from Spain to the Euphrates. Roman legions, renowned for their discipline and engineering prowess, secured and maintained these vast territories, building roads, fortifications, and cities that facilitated control and integration.
The Roman Empire’s society was hierarchical, with a rigid class system. At the top were the patricians, wealthy elites who held significant political power. Below them were the plebeians, free citizens with limited political influence, and the vast numbers of slaves who formed the backbone of the economy. The family unit was central, governed by the paterfamilias, the male head who held absolute authority.
Culturally, the Romans were eclectic, absorbing and adapting elements from the civilizations they encountered, particularly the Greeks. Roman art, literature, and philosophy reflected this synthesis, creating a rich cultural tapestry. Latin, the Roman language, became the lingua franca of the Western world, influencing numerous modern languages.
Roman architecture and engineering achievements were monumental. They perfected the arch, vault, and dome, constructing enduring structures like the Colosseum, Pantheon, and aqueducts. These engineering marvels not only showcased Roman ingenuity but also served practical purposes, from public entertainment to water supply.
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
3. CCBs are potent anti-hypertensive agents.
Favored in management of hypertension as
monotherapy/combination therapy.
Gaps remain in therapy with CCBs in terms of
end organ protection & incidence of distressing
adverse effects.
3
JNC VIII RECOMMENDS CCBS AS FIRST LINE
ANTIHYPERTENSIVE AGENTS
JAMA. 2014;311(5):507-520.
4. • Amlodipine: Evidence based CCB
Trial
ALLHAT
ASCOT -
BPLA
ACCOMPL
ISH
VALUE
No of
Patients
42,000
19,257
11,506
15245
Follow up
(years)
4.9
5.5
3
4.2
Results
Amlodipine >
ACEI
Amlodipine > B
Blockers
Amlodipine >
Diuretics
Amlodipine
>ARB
Amlodipine has proven its CV efficacy and safety against all
other 1st line antihypertensive.
Among CCBs, amlodipine is widely evaluated for improvement of CV
outcomes in hypertensive in multiple large randomized clinical trials
5. GAPS IN THERAPY OF HYPERTENSION
WITH CCBS
Inadequate Cardiac Protection:
1. Vasodilatation induced Reflex Tachycardia
2. Inadequate correction of myocardial ischaemia
3. Persistent Risk of Arrhythmia
4. Hypertrophy & Remodeling of cardiac myocytes
5. No anti-platelet action
5
6. GAPS IN THERAPY OF HYPERTENSION
WITH CCBS
Inadequate Vascular Protection:
1. Progressive Endothelial Dysfunction
2. Accelerated atherosclerosis
3. Reactive Oxygen Species mediated vascular damage
Inadequate Cerebrovascular Protection:
1. Increased risk of stroke
2. No protection from progressive decline of cognition
Distressing Side Effects:
1. Peripheral oedema
2. Constipation
3. Flushing
4. Palpitations & Tachycardia
6
7. NEWER CCB BRIDGES THE
GAPS
7
Dual & triple blockade of calcium channels may offer additional benefits.
9. NEGLIGIBLE PEDAL OEDEMA
**International Prescribing Informations
SIDE EFFECT** Efonidipine Amlodipine Cilnidipine Benidipine
PEDAL
OEDEMA <0.1% 5-16% Up to 5% Up to 5%
Pedal oedema is the most frequently
encountered side effect with CCBs
Responsible for therapy discontinuation in
significant number of patients
Conventional CCBs produce pedal oedema by
predominant pre-capillary dilatation
“Incidence of pedal oedema with
Efonidipine is negligible due to its
balanced dilatation of pre & post-capillary
vessels”
10. AZELNIDIPINE
• Azelnidipine is a new dihydropyridine calcium channel
antagonist.
• It is L and T type of calcium channel blocker.
• Composed of a racemic mixture containing a 1:1 ratio of
the active R-enantiomer and the inactive S-enantiomer.
Drugs 2003; 63 (23): 2613-2621
11. MECHANISM OF ACTION OF AZELNIDIPINE
Blocks L-Type calcium channel in blood vessel and T-type
Calcium channel in heart.
Results in vasodilation and reduced heart rate.
Thus continues to produce long-term antihypertensive
effect.
It shows gradual fall in BP, hence does not induce reflex
tachycardia.
Drugs 2003; 63 (23): 2613-2621
12. DOSAGE AND INDICATIONS
Azelnidipine tablets 16 mg.
For the treatment of Essential Hypertension.
CDSCO site
Approved by
DCGI
USE IN SPECIFIC POPULATION
Severe renal Impairment: Efficacy have not been established
Severe hepatic impairment: Efficacy have not been established
Pediatric Use: Efficacy have not been established
Elderly Use: Low dose (8 mg once daily) is recommended
Pregnancy: Not recommended
Nursing mother: Not recommended
13. EFFECTS PROVEN IN PRE-CLINICAL STUDIES
Negative chronotropic effect 1
Inhibit Aldosterone synthesis and secretion 2
Dilate efferent arterioles 3
Preserves insulin signaling and glucose uptake 3
1. Journal of Hypertension 2014, 32:1898–1904
2. Eur J Pharmacol. 2009 Mar 1;605(1-3):49-52
3. Drugs R D (2013) 13:63–73
4. Endocrine Journal 2015, 62 (8), 741-747
14. Kozo Yao ,et al. Journal of pharmacological sciences: 2006: 100 (4) : 243-61
Triple calcium channel blocking effect
Benidipine inhibits not only the L-type Ca2+ channel, but also especially
inhibits the N-type and T-type Ca2+ channels.
Its triple Ca2+-channel blocking effects, are involved in the
pharmacological actions of this drug, such as its renoprotective
effect.
BENEDIPINE
Dose 4-8 mg BD
15. Cardio-protective & anti-atherosclerotic effects of Benidipine
Kozo Yao ,et al. Journal of pharmacological
Benidipine has anti-oxidative activity
Stimulates NO production
Suppresses the expression of adhesion
molecules
Suppresses the proliferation of vascular
smooth muscles
Suppresses the proliferation of mesangial cells
Protects the myocardium
16. CILINIDIPINE
Demonstrates significant sympatholytic action.
Attenuates platelet activation (and consequent arterial
thrombosis), tachycardia, oxidative stress, and also inhibits
activation of renin-angiotensin system in blood vessels.
17. •Cilnidipine improves the ambulatory BP and HR profile.
•Significant suppression of LVH in hypertensive CKD
patients.
Dose 5-10 mg OD, Maximum dose
20mg
19. NEGATIVE CHRONOTROPIC EFFECT
Efonidipine regulate heart rate
(HR) by inhibiting T-type
calcium channels, which are
localized primarily in SA node &
are involved in pacemaker
mechanism of heart.
Cardiovasculnr Drug Reviews, Vol. 12, No. 2, 1994
Antihypertensive effect by blocking L-type calcium channels causes
reflex tachycardia by sympathetic drive
Reduces SNS activity & enhances PNS activity
20. ANTIANGINAL ACTION
Efonidipine reduces myocardial oxygen demand &
improves coronary blood supply:
T-type Ca2+ channel blockade in SA Node reduces heart rate
Reduction in heart rate lowers myocardial oxygen demand
T-type Ca2+ channel blockade in coronary vasculature dilates
coronary blood vessels & coronary blood flow
Increased coronary blood flow ameliorates myocardial ischaemia
1.Curr Ther Res Clin Exp. 2003 Nov;64(9):707-14 2.Journal of Human Hypertension.2002);16: 539-547
LONG TERM CARDIOPROTECTION
• Efonidipine lowers circulating Aldosterone levels by
blocking T-type Ca2+ channels in the adrenal cortex
• Prevents Aldosterone induced cardiac hypertrophy &
remodeling
21. ANTI-ARRHYTHMOGENIC ACTION
Efonidipine the risk of SVTs and
prevents AF from becoming
permanent by blocking T-type
channels
. J Atheroscler Thromb. 2009 Oct; 16(5): 568-75.
22. ROLE IN ENDOTHELIAL PROTECTION &
ANTI-OXIDANT ACTIVITY
Efonidipine 8-hydroxy-2`-
deoxy Guanosine (8-OH-dG) &
Malondialdehyde-modified LDL
(markers of oxidative damage)
and improves endothelial
function
Diabetes Care.2007 Jun;30(6):1605-7.
23. ANTI-ATHEROGENIC ACTION
Prevention of
platelet/monocyte
activation & release of
cell adhesion molecules
Reduces atherosclerotic
plaque size by
preventing cholesterol
ester deposition in them
Prevents proliferation of
smooth muscle cells in
the arteries
. J Atheroscler Thromb. 2009 Oct; 16(5): 568-75.
24. ANTI-PLATELET ACTION
Efonidipine therapy
significantly reduces
markers of platelet
activation.
Efonidipine prevents
platelet activation and
reduces the risk of
vascular injury and
atherosclerosis.
J Hum Hypertens. 2002 Aug;16(8):539-47.
25. REDUCES INSULIN RESISTANCE
• Efonidipine lowers Insulin
Resistance by blocking the T-
type channels
• Improves glycemic control
Springer Vienna. 2015; 137-150.
26. TAKE HOME POINTS
Unique novel CCB (L,N & T-type) with potent anti-
hypertensive action & myriad of Pleiotropic Effects
• Superior renoprotective action by blockade of T-type calcium channels in
the kidneys & adrenal glands.
• Enhanced cardioprotective action & significant anti-anginal effect.
• Superior vasculoprotection with pronounced anti-oxidant & anti-atherogenic
activity.
• Offers cerebroprotection & prevents decline in cognitive function.
• Unique anti-platelet activity & improves insulin resistance.
• Unmatched safety profile: Least incidence of
Pedal oedema
Constipation
Palpitation
Flushing